The American public’s trust in healthcare institutions, long a matter of common courtesy, fell off a cliff after the COVID-19 crisis. Two academic physicians propose a treatment pathway for the injured patient—aka our healthcare system’s reputation for reliability.
A variety of CPT code changes take effect in 2026, and many of them will make a direct impact on interventional cardiology. Arnold Seto, MD, spoke to Cardiovascular Business about these updates for a new video interview.
Mitral valve surgery can be especially challenging when patients present with a small mitral valve area. When it comes to M-TEER, however, treatment still appears to be both safe and effective.
MRI is an essential tool for diagnosing and managing the disease, but poor image quality and interpretation variability continue to hinder its widespread adoption
According to a new study of nearly 7,000 patients, type 1 and type 2 diabetes are both linked to significantly shorter life expectancies. The risk of sudden cardiac death appears to be highest for younger patients.
Interventional cardiology's second Match Day was a significant success. Due to a lack of candidates, however, dozens of fellowship positions remain unfilled.
The American public’s trust in healthcare institutions, long a matter of common courtesy, fell off a cliff after the COVID-19 crisis. Two academic physicians propose a treatment pathway for the injured patient—aka our healthcare system’s reputation for reliability.
![The use of intravascular lithotripsy (IVL) during percutaneous coronary intervention (PCI) is still safe and effective when patients present with calcified nodules (CNs), according to new long-term data published in EuroIntervention.[1] Researchers compared outcomes from patients with and without CNs, highlighting key similarities in stent expansion and luminal gain.](/sites/default/files/styles/stack_views/public/2024-12/screenshot_2024-12-02_at_11.07.21_am.png.webp?itok=WCWcIaTj)
